Akebia Therapeutics Inc. (NASDAQ: AKBA) Shares Declined By -9.21% In One Month.

In the latest trading session, 1.02 million Akebia Therapeutics Inc. (NASDAQ:AKBA) shares changed hands as the company’s beta touched 0.78. With the company’s most recent per share price at $1.03 changed hands at -$0.04 or -3.27% at last look, the market valuation stands at $216.94M. AKBA’s current price is a discount, trading about -140.78% off its 52-week high of $2.48. The share price had its 52-week low at $0.78, which suggests the last value was 24.27% up since then. When we look at Akebia Therapeutics Inc.’s average trading volume, we note the 3-month average coming to 4.93 million.

Akebia Therapeutics Inc. (NASDAQ:AKBA) trade information

Instantly AKBA was in red as seen in intraday trades today. With action -5.05%, the performance over the past five days has been red. The drop to weekly highs of 1.1950 subtracted -3.27% to the stock’s daily price. The company’s shares are showing year-to-date downside of -16.53%, with the 5-day performance at -5.05% in the red. However, in the 30-day time frame, Akebia Therapeutics Inc. (NASDAQ:AKBA) is -9.21% down.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Akebia Therapeutics Inc. (AKBA) estimates and forecasts

Data shows that the Akebia Therapeutics Inc. share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -8.41% over the past 6 months, a 0.00% in annual growth rate that is considerably lower than the industry average of 13.90%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 35.46%. The 2024 estimates are for Akebia Therapeutics Inc. earnings to decrease by -2.38%.